pyrazines has been researched along with Anankastic Personality in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgarten, HG; Grozdanovic, Z | 1 |
Kindler, S; Zohar, J | 1 |
Barr, LC; Charney, DS; Goodman, WK; McDougle, CJ; Price, LH | 1 |
Bastani, B; Meltzer, HY; Nash, JF | 1 |
2 review(s) available for pyrazines and Anankastic Personality
Article | Year |
---|---|
Role of serotonin in obsessive-compulsive disorder.
Topics: Biogenic Monoamines; Fenfluramine; Humans; Neuropeptides; Obsessive-Compulsive Disorder; Piperazines; Pyrazines; Pyrimidines; Serotonin; Serotonin Syndrome; Synaptic Transmission; Tryptophan | 1998 |
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
Topics: Biomarkers; Clomipramine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Piperazines; Pyrazines; Pyrimidines; Serotonin | 1992 |
2 trial(s) available for pyrazines and Anankastic Personality
Article | Year |
---|---|
Update of the serotonergic hypothesis of obsessive compulsive disorder.
Topics: Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Piperazines; Pyrazines; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin Antagonists | 1992 |
Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Female; Humans; Hydrocortisone; Male; Middle Aged; Obsessive-Compulsive Disorder; Prolactin; Pyrazines; Receptors, Serotonin; Serotonin | 1990 |